SCHEMBL6209845

SCHEMBL6209845

NC(=O)CCCC(=O)N1CCC2C1C(=O)CN2S(=O)(=O)c1ccc[nH]c1=O

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.30
NPC1 O15118 1/20 0.30
SMYD3 Q9H7B4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6214307 0.85 CTSK (0.31) SMYD3
SCHEMBL6209599 0.80 PLD2 (0.36) DPP4
SCHEMBL6210471 0.80 LMNA (0.40) DPP4NPC1
SCHEMBL6209393 0.80 CTSL (0.36) SMYD3
SCHEMBL6209199 0.79
SCHEMBL6211627 0.79
SCHEMBL6209388 0.78 CTSK (0.32) SMYD3
SCHEMBL6211156 0.77 CHRM4 (0.41) DPP4
SCHEMBL6210999 0.75 MAPK8 (0.30)
SCHEMBL6209760 0.74 MT-CO2 (0.33) DPP4NPC1SMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed